Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-005062-19Phase 4Completed
Phase 4 trial of aciclovir in herpes simplex (HSV), sponsored by Medical University of Graz. Primary endpoint: AUC0-t of acyclovir in dermal interstitial fluid. Started Dec 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-005062-19.